PROVEN
SKYRIZI RESULTS

Take Control of Ulcerative Colitis With Relief, Repair, and Remission

Already approved for adults with moderate to severe Crohn’s disease, SKYRIZI can deliver significant results in ulcerative colitis (UC). 

In clinical trials, SKYRIZI helped patients experience remission at 12 weeks and 1 year.

*Based on fewer bowel movements and bloody stools.

Areas that were visually assessed may not represent repair of the entire colon lining.

Feel Significant Symptom Relief

IN ONLY 4 WEEKS, 53% OF PEOPLE HAD:

Fewer Bowel Movements and Bloody Stools

+

Fewer Bloody Stools

AND AT 12 WEEKS:

No Bowel Movements During Sleep

67% had no accidents or bathroom trips during sleep.

No Bowel Urgency

Many had no bowel urgency.

Less Fatigue

People experienced significantly less UC fatigue.

Experience Early and Lasting Visible Colon Lining Repair

SKYRIZI patients who achieved visible colon lining repair at:

12 WEEKS

In an induction trial, SKYRIZI helped many people achieve visible colon lining repair at 12 weeks.

36%

36%

1200 mg starter IV§ infusion

1 YEAR

In a maintenance trial,|| among people who were eligible and entered, SKYRIZI helped the majority achieve visible colon lining repair at 1 year.

51%

51%

180 mg SC maintenance injection

48%

Many achieved visible colon lining repair taking 360 mg SC

Your doctor will decide what maintenance dose is right for you.

Visible colon lining repair, also called “endoscopic improvement,” is a reduction in inflammation in the colon lining that your doctor can see—and controlling it is an important part of managing UC.

Areas that were visually assessed may not represent repair of the entire colon lining.

See What SKYRIZI Repair Can Look Like

Before SKYRIZI

12 Weeks

1 Year

Real clinical trial endoscopy images from a patient who received SKYRIZI 1200 mg during induction and 180 mg during maintenance. Patient achieved visible colon lining repair at 12 weeks and 1 year.

Individual results may vary.

Achieve Lasting Remission With SKYRIZI

SKYRIZI is proven to deliver early remission at 12 weeks and lasting remission at 1 year, which means few to no symptoms (like frequent bowel movements and bloody stools) and visible repair of the colon lining.

12

WEEKS

In an induction trial, SKYRIZI helped some people achieve remission at 12 weeks.

1

YEAR

In a maintenance trial,|| among those who were eligible and entered, SKYRIZI helped many people achieve lasting remission at 1 year.

Areas that were visually assessed may not represent repair of the entire colon lining.

Results are from a clinical trial of 646 people who took SKYRIZI.

§Intravenous infusion (through a vein in the arm).

|| 365 people who achieved a clinical response after 12 weeks of SKYRIZI induction and entered the maintenance trial. Clinical response is based on frequency of bowel movements, fewer bloody stools, and endoscopy results.

Subcutaneous injection (under the skin).

LET’S GET STARTED

Which SKYRIZI results would you want to discuss further with your doctor?

Symptom relief

That’s a really important treatment goal for UC! Our UC Impact Assessment can help you bring up topics like this with your doctor. 

Go to the UC Impact Assessment

Visible colon lining repair

That’s a really important treatment goal for UC! Our UC Impact Assessment can help you bring up topics like this with your doctor. 

Go to the UC Impact Assessment

Remission

That’s a really important treatment goal for UC! Our UC Impact Assessment can help you bring up topics like this with your doctor. 

Go to the UC Impact Assessment

Up Next

Explore more about SKYRIZI, a biologic proven to help deliver results in UC.

Recommended for You

Learn how to make SKYRIZI part of your routine.

Answer 5 quick questions to better understand how UC is impacting you.